Article
ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies.
Molecular neurodegeneration - 8 Nov 2022
Raulin Ana-Caroline, Doss Sydney V, Trottier Zachary A, Ikezu Tadafumi C, Bu Guojun, Liu Chia-Chen
Abstract excerpt
Alzheimer's disease (AD) is the most common cause of dementia worldwide, and its prevalence is rapidly increasing due to extended lifespans. Among the increasing number of genetic risk factors identified, the apolipoprotein E (APOE) gene remains the strongest and most prevalent, impacting more than half of all AD cases. While the ε4 allele of the APOE gene significantly increases AD risk, the ε2 allele is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.